Reneo Pharmaceuticals, Inc. (RPHM) Stock Analysis

DELISTED 2024

What happened to Reneo Pharmaceuticals, Inc. (RPHM) stock?

Reneo Pharmaceuticals, Inc. (RPHM) no longer trades on public markets. It was delisted in October 2024. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: October 2024
Last recorded price (historical):: $18.20 (last quote on record before the October 2024 delisting; historical, not a current quote)

MCap: $60.8M| Vol: 437.5K| 52-wk range: $1.68 – $82.90

Market cap $60.8M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Reneo Pharmaceuticals, Inc. (RPHM). Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing therapies for rare genetic mitochondrial diseases. Their lead candidate, REN001, is undergoing clinical trials for primary mitochondrial myopathies and other metabolic disorders.

Last analyzed: Mar 16, 2026

Reneo Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing therapies for rare genetic mitochondrial diseases. Their lead candidate, REN001, is undergoing clinical trials for primary mitochondrial myopathies and other metabolic disorders.

These figures come from statements filed 13 months ago — the most recent this company has published.

Reneo Pharmaceuticals, Inc. (RPHM) Healthcare & Pipeline Overview

Employees8

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 71% (not a measure of the evidence) Updated: Mar 16, 2026

More about this archive record

Can I still buy RPHM shares?

No. RPHM stopped trading on public markets in October 2024, so the shares are not available through a broker. Anything you see quoted for RPHM elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before RPHM stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Reneo Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Mar 16, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Mar 16, 2026.

Data provided for informational purposes only.